Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE: 000623)
Health Care · Pharmaceuticals · CN
CN¥17.41
-0.40% today · -14.3% 1Y
Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE: 000623) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.04B and employs 5,461 people.
Over the last twelve months the share price has lost 14.3%, trading between 16.36 and 22.08.
Tweenvest scores Jilin Aodong Pharmaceutical Group Co., Ltd. across four factors: quality 68/100, value 54/100, growth 18/100, dividend 64/100. Its strongest factor is quality.
000623 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.04B
- Revenue (TTM)
- $329.73M
- P/E
- 6.45
- EPS
- 2.70
- Dividend yield
- 2.87%
- Beta (5Y)
- 0.53
- 52-week high
- CN¥22.08
- 52-week low
- CN¥16.36
- Avg volume (3M)
- —
- Shares outstanding
- 1.17B
- Employees
- 5,461
- Next earnings
- —
About Jilin Aodong Pharmaceutical Group Co., Ltd.
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
- ISIN
- CNE000000719
- Founded
- 1957
- Listed since
- Oct 28, 1996
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd.SZSE: 300255 | $3.14B | CN¥22.94 | -0.74% |
| Tasly Pharmaceutical Group Co., LtdSHSE: 600535 | $3.12B | CN¥14.00 | +2.34% |
| Sunshine Lake Pharma Co., Ltd.SEHK: 6887 | $3.09B | HK$42.12 | +6.36% |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd.SZSE: 002317 | $3.04B | CN¥24.03 | +2.91% |
| Chengdu Kanghong Pharmaceutical Group Co., LtdSZSE: 002773 | $2.99B | CN¥21.80 | +6.76% |
| Enliven Therapeutics, Inc.NasdaqGS: ELVN | $2.98B | $40.63 | -1.76% |
| Virbac SAENXTPA: VIRP | $2.96B | €315.50 | -0.79% |
| Neuland Laboratories LimitedBSE: 524558 | $2.86B | Rs21,496.30 | -1.86% |
Figures last refreshed Oct 4, 2026.